DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Edeline J, Boucher E, Rolland Y , et al.
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma.
Cancer 2012;
118 (1) 147-156
We do not assume any responsibility for the contents of the web pages of other providers.